Congress Turns Up Heat For More Information On FDA Performance, Funding

During a Jan. 29 hearing on FDA's "Science and Mission at Risk" FDA Commissioner Andrew von Eschenbach told a House subcommittee the agency is fulfilling its responsibilities, but acknowledged additional funding and other resources are needed

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet